Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444935131
总结
CYP2D6 poor metabolizers are not associated with increased risk of Recurrence when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 normal metabolizers.